Log In
Print
BCIQ
Print
Print this Print this
 

Edarbi, azilsartan medoxomil (TAK-491)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOral angiotensin II type 1 (AT1) receptor blocker (ARB)
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner

Arbor Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today